Free Trial
LON:BXP

Beximco Pharmaceuticals (BXP) Share Price, News & Analysis

Beximco Pharmaceuticals logo
GBX 45.62 -0.88 (-1.89%)
As of 09/5/2025 07:37 AM Eastern

About Beximco Pharmaceuticals Stock (LON:BXP)

Key Stats

Today's Range
45.62
46.50
50-Day Range
34.26
50
52-Week Range
21
52.33
Volume
6,165 shs
Average Volume
50,036 shs
Market Capitalization
£203.52 million
P/E Ratio
3.20
Dividend Yield
8.70%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beximco Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BXP Stock News Headlines

6-Figure Target for BTC by 2025
Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure for what could be the largest bull run in crypto history...and you can piggyback on their moves.tc pixel
Annual General Meeting Statement
See More Headlines

BXP Stock Analysis - Frequently Asked Questions

Beximco Pharmaceuticals' stock was trading at GBX 38.20 at the beginning of the year. Since then, BXP shares have increased by 19.4% and is now trading at GBX 45.62.

Shares of BXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Beximco Pharmaceuticals investors own include Advanced Micro Devices (AMD), Bank of America (BAC), Exxon Mobil (XOM), Salesforce (CRM), Chevron (CVX), Meta Platforms (META) and NIKE (NKE).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Trading
Current Symbol
LON:BXP
CIK
N/A
Fax
N/A
Employees
5,500
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 14.25
Trailing P/E Ratio
3.20
Forward P/E Ratio
5.10
P/E Growth
N/A
Net Income
£970.84 billion
Net Margins
13.71%
Pretax Margin
N/A
Return on Equity
13.12%
Return on Assets
6.97%

Debt

Debt-to-Equity Ratio
12.47
Current Ratio
2.13
Quick Ratio
0.37

Sales & Book Value

Annual Sales
£46.34 billion
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
£120.21 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
446,112,000
Free Float
N/A
Market Cap
£203.52 million
Optionable
Not Optionable
Beta
0.61
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (LON:BXP) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners